0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anti-Vimentin Antibody Market Research Report 2026
Published Date: 2026-03-20
|
Report Code: QYRE-Auto-22H17401
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Anti Vimentin Antibody Market Research Report 2024
BUY CHAPTERS

Global Anti-Vimentin Antibody Market Research Report 2026

Code: QYRE-Auto-22H17401
Report
2026-03-20
Pages:122
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Anti-Vimentin Antibody Market

The global Anti-Vimentin Antibody market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Anti-Vimentin Antibody competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Anti-vimentin antibody is a specific antibody that binds to the vimentin protein, a type iii intermediate filament protein essential for maintaining cell structure and integrity, frequently employed in research to study cell migration, epithelial-to-mesenchymal transition, and cytoskeletal dynamics related to vimentin expression.
The North American market for Anti-Vimentin Antibody is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Anti-Vimentin Antibody is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Anti-Vimentin Antibody include Thermo Fisher Scientific, Nordic, Abcam, Genetex, PROGEN, Bio-Rad, Boster Bio, Sino Biological, Arigo Biolaboratories, Aves Labs, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Anti-Vimentin Antibody market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Anti-Vimentin Antibody. The Anti-Vimentin Antibody market size, estimates, and forecasts are provided in terms of sales volume (kg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Anti-Vimentin Antibody market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Anti-Vimentin Antibody manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Anti-Vimentin Antibody Market Report

Report Metric Details
Report Name Anti-Vimentin Antibody Market
Segment by Type
  • Monoclonal Anti-Vimentin Antibody
  • Polyclonal Anti-Vimentin Antibody
by Application
  • Immunocytochemistry
  • Flow Cytometry
  • Immunochemistry
  • Western Blot
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Thermo Fisher Scientific, Nordic, Abcam, Genetex, PROGEN, Bio-Rad, Boster Bio, Sino Biological, Arigo Biolaboratories, Aves Labs, Raybiotech, Biolegend, Roche Diagnostics, Rockland Immunochemicals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Anti-Vimentin Antibody manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Anti-Vimentin Antibody sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Anti-Vimentin Antibody Market report?

Ans: The main players in the Anti-Vimentin Antibody Market are Thermo Fisher Scientific, Nordic, Abcam, Genetex, PROGEN, Bio-Rad, Boster Bio, Sino Biological, Arigo Biolaboratories, Aves Labs, Raybiotech, Biolegend, Roche Diagnostics, Rockland Immunochemicals

What are the Application segmentation covered in the Anti-Vimentin Antibody Market report?

Ans: The Applications covered in the Anti-Vimentin Antibody Market report are Immunocytochemistry, Flow Cytometry, Immunochemistry, Western Blot, Others

What are the Type segmentation covered in the Anti-Vimentin Antibody Market report?

Ans: The Types covered in the Anti-Vimentin Antibody Market report are Monoclonal Anti-Vimentin Antibody, Polyclonal Anti-Vimentin Antibody

1 Anti-Vimentin Antibody Market Overview
1.1 Product Definition
1.2 Anti-Vimentin Antibody by Type
1.2.1 Global Anti-Vimentin Antibody Market Value by Type: 2025 vs 2032
1.2.2 Monoclonal Anti-Vimentin Antibody
1.2.3 Polyclonal Anti-Vimentin Antibody
1.3 Anti-Vimentin Antibody by Application
1.3.1 Global Anti-Vimentin Antibody Market Value by Application: 2025 vs 2032
1.3.2 Immunocytochemistry
1.3.3 Flow Cytometry
1.3.4 Immunochemistry
1.3.5 Western Blot
1.3.6 Others
1.4 Global Anti-Vimentin Antibody Market Size Estimates and Forecasts
1.4.1 Global Anti-Vimentin Antibody Revenue 2021–2032
1.4.2 Global Anti-Vimentin Antibody Sales 2021–2032
1.4.3 Global Anti-Vimentin Antibody Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Anti-Vimentin Antibody Market Competition by Manufacturers
2.1 Global Anti-Vimentin Antibody Sales Market Share by Manufacturers (2021–2026)
2.2 Global Anti-Vimentin Antibody Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Anti-Vimentin Antibody Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Anti-Vimentin Antibody, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Anti-Vimentin Antibody, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Anti-Vimentin Antibody, Product Types and Applications
2.7 Global Key Manufacturers of Anti-Vimentin Antibody, Date of Entry into the Industry
2.8 Global Anti-Vimentin Antibody Market Competitive Situation and Trends
2.8.1 Global Anti-Vimentin Antibody Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Anti-Vimentin Antibody Players Market Share by Revenue
2.8.3 Global Anti-Vimentin Antibody Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Anti-Vimentin Antibody Market Scenario by Region
3.1 Global Anti-Vimentin Antibody Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Anti-Vimentin Antibody Sales by Region: 2021–2032
3.2.1 Global Anti-Vimentin Antibody Sales by Region: 2021–2026
3.2.2 Global Anti-Vimentin Antibody Sales by Region: 2027–2032
3.3 Global Anti-Vimentin Antibody Revenue by Region: 2021–2032
3.3.1 Global Anti-Vimentin Antibody Revenue by Region: 2021–2026
3.3.2 Global Anti-Vimentin Antibody Revenue by Region: 2027–2032
3.4 North America Anti-Vimentin Antibody Market Facts & Figures by Country
3.4.1 North America Anti-Vimentin Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Anti-Vimentin Antibody Sales by Country (2021–2032)
3.4.3 North America Anti-Vimentin Antibody Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Anti-Vimentin Antibody Market Facts & Figures by Country
3.5.1 Europe Anti-Vimentin Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Anti-Vimentin Antibody Sales by Country (2021–2032)
3.5.3 Europe Anti-Vimentin Antibody Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-Vimentin Antibody Market Facts & Figures by Region
3.6.1 Asia Pacific Anti-Vimentin Antibody Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Anti-Vimentin Antibody Sales by Region (2021–2032)
3.6.3 Asia Pacific Anti-Vimentin Antibody Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Anti-Vimentin Antibody Market Facts & Figures by Country
3.7.1 Latin America Anti-Vimentin Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Anti-Vimentin Antibody Sales by Country (2021–2032)
3.7.3 Latin America Anti-Vimentin Antibody Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Anti-Vimentin Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-Vimentin Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Anti-Vimentin Antibody Sales by Country (2021–2032)
3.8.3 Middle East and Africa Anti-Vimentin Antibody Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti-Vimentin Antibody Sales by Type (2021–2032)
4.1.1 Global Anti-Vimentin Antibody Sales by Type (2021–2026)
4.1.2 Global Anti-Vimentin Antibody Sales by Type (2027–2032)
4.1.3 Global Anti-Vimentin Antibody Sales Market Share by Type (2021–2032)
4.2 Global Anti-Vimentin Antibody Revenue by Type (2021–2032)
4.2.1 Global Anti-Vimentin Antibody Revenue by Type (2021–2026)
4.2.2 Global Anti-Vimentin Antibody Revenue by Type (2027–2032)
4.2.3 Global Anti-Vimentin Antibody Revenue Market Share by Type (2021–2032)
4.3 Global Anti-Vimentin Antibody Price by Type (2021–2032)
5 Segment by Application
5.1 Global Anti-Vimentin Antibody Sales by Application (2021–2032)
5.1.1 Global Anti-Vimentin Antibody Sales by Application (2021–2026)
5.1.2 Global Anti-Vimentin Antibody Sales by Application (2027–2032)
5.1.3 Global Anti-Vimentin Antibody Sales Market Share by Application (2021–2032)
5.2 Global Anti-Vimentin Antibody Revenue by Application (2021–2032)
5.2.1 Global Anti-Vimentin Antibody Revenue by Application (2021–2026)
5.2.2 Global Anti-Vimentin Antibody Revenue by Application (2027–2032)
5.2.3 Global Anti-Vimentin Antibody Revenue Market Share by Application (2021–2032)
5.3 Global Anti-Vimentin Antibody Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Thermo Fisher Scientific
6.1.1 Thermo Fisher Scientific Company Information
6.1.2 Thermo Fisher Scientific Description and Business Overview
6.1.3 Thermo Fisher Scientific Anti-Vimentin Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Thermo Fisher Scientific Anti-Vimentin Antibody Product Portfolio
6.1.5 Thermo Fisher Scientific Recent Developments/Updates
6.2 Nordic
6.2.1 Nordic Company Information
6.2.2 Nordic Description and Business Overview
6.2.3 Nordic Anti-Vimentin Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Nordic Anti-Vimentin Antibody Product Portfolio
6.2.5 Nordic Recent Developments/Updates
6.3 Abcam
6.3.1 Abcam Company Information
6.3.2 Abcam Description and Business Overview
6.3.3 Abcam Anti-Vimentin Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Abcam Anti-Vimentin Antibody Product Portfolio
6.3.5 Abcam Recent Developments/Updates
6.4 Genetex
6.4.1 Genetex Company Information
6.4.2 Genetex Description and Business Overview
6.4.3 Genetex Anti-Vimentin Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Genetex Anti-Vimentin Antibody Product Portfolio
6.4.5 Genetex Recent Developments/Updates
6.5 PROGEN
6.5.1 PROGEN Company Information
6.5.2 PROGEN Description and Business Overview
6.5.3 PROGEN Anti-Vimentin Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 PROGEN Anti-Vimentin Antibody Product Portfolio
6.5.5 PROGEN Recent Developments/Updates
6.6 Bio-Rad
6.6.1 Bio-Rad Company Information
6.6.2 Bio-Rad Description and Business Overview
6.6.3 Bio-Rad Anti-Vimentin Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Bio-Rad Anti-Vimentin Antibody Product Portfolio
6.6.5 Bio-Rad Recent Developments/Updates
6.7 Boster Bio
6.7.1 Boster Bio Company Information
6.7.2 Boster Bio Description and Business Overview
6.7.3 Boster Bio Anti-Vimentin Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Boster Bio Anti-Vimentin Antibody Product Portfolio
6.7.5 Boster Bio Recent Developments/Updates
6.8 Sino Biological
6.8.1 Sino Biological Company Information
6.8.2 Sino Biological Description and Business Overview
6.8.3 Sino Biological Anti-Vimentin Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Sino Biological Anti-Vimentin Antibody Product Portfolio
6.8.5 Sino Biological Recent Developments/Updates
6.9 Arigo Biolaboratories
6.9.1 Arigo Biolaboratories Company Information
6.9.2 Arigo Biolaboratories Description and Business Overview
6.9.3 Arigo Biolaboratories Anti-Vimentin Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Arigo Biolaboratories Anti-Vimentin Antibody Product Portfolio
6.9.5 Arigo Biolaboratories Recent Developments/Updates
6.10 Aves Labs
6.10.1 Aves Labs Company Information
6.10.2 Aves Labs Description and Business Overview
6.10.3 Aves Labs Anti-Vimentin Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Aves Labs Anti-Vimentin Antibody Product Portfolio
6.10.5 Aves Labs Recent Developments/Updates
6.11 Raybiotech
6.11.1 Raybiotech Company Information
6.11.2 Raybiotech Description and Business Overview
6.11.3 Raybiotech Anti-Vimentin Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Raybiotech Anti-Vimentin Antibody Product Portfolio
6.11.5 Raybiotech Recent Developments/Updates
6.12 Biolegend
6.12.1 Biolegend Company Information
6.12.2 Biolegend Description and Business Overview
6.12.3 Biolegend Anti-Vimentin Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Biolegend Anti-Vimentin Antibody Product Portfolio
6.12.5 Biolegend Recent Developments/Updates
6.13 Roche Diagnostics
6.13.1 Roche Diagnostics Company Information
6.13.2 Roche Diagnostics Description and Business Overview
6.13.3 Roche Diagnostics Anti-Vimentin Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Roche Diagnostics Anti-Vimentin Antibody Product Portfolio
6.13.5 Roche Diagnostics Recent Developments/Updates
6.14 Rockland Immunochemicals
6.14.1 Rockland Immunochemicals Company Information
6.14.2 Rockland Immunochemicals Description and Business Overview
6.14.3 Rockland Immunochemicals Anti-Vimentin Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Rockland Immunochemicals Anti-Vimentin Antibody Product Portfolio
6.14.5 Rockland Immunochemicals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-Vimentin Antibody Industry Chain Analysis
7.2 Anti-Vimentin Antibody Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-Vimentin Antibody Production Mode & Process Analysis
7.4 Anti-Vimentin Antibody Sales and Marketing
7.4.1 Anti-Vimentin Antibody Sales Channels
7.4.2 Anti-Vimentin Antibody Distributors
7.5 Anti-Vimentin Antibody Customer Analysis
8 Anti-Vimentin Antibody Market Dynamics
8.1 Anti-Vimentin Antibody Industry Trends
8.2 Anti-Vimentin Antibody Market Drivers
8.3 Anti-Vimentin Antibody Market Challenges
8.4 Anti-Vimentin Antibody Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Anti-Vimentin Antibody Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Anti-Vimentin Antibody Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Anti-Vimentin Antibody Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Anti-Vimentin Antibody Sales (kg) of Key Manufacturers (2021–2026)
 Table 5. Global Anti-Vimentin Antibody Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Anti-Vimentin Antibody Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Anti-Vimentin Antibody Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Anti-Vimentin Antibody Average Price (US$/kg) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Anti-Vimentin Antibody, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Anti-Vimentin Antibody, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Anti-Vimentin Antibody, Product Types and Applications
 Table 12. Global Key Manufacturers of Anti-Vimentin Antibody, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Anti-Vimentin Antibody Companies by Tier (Tier 1, Tier 2, Tier 3), based on Anti-Vimentin Antibody Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Anti-Vimentin Antibody Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Anti-Vimentin Antibody Sales by Region (kg), 2021–2026
 Table 18. Global Anti-Vimentin Antibody Sales Market Share by Region (2021–2026)
 Table 19. Global Anti-Vimentin Antibody Sales by Region (kg), 2027–2032
 Table 20. Global Anti-Vimentin Antibody Sales Market Share by Region (2027–2032)
 Table 21. Global Anti-Vimentin Antibody Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Anti-Vimentin Antibody Revenue Market Share by Region (2021–2026)
 Table 23. Global Anti-Vimentin Antibody Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Anti-Vimentin Antibody Revenue Market Share by Region (2027–2032)
 Table 25. North America Anti-Vimentin Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Anti-Vimentin Antibody Sales by Country (kg), 2021–2026
 Table 27. North America Anti-Vimentin Antibody Sales by Country (kg), 2027–2032
 Table 28. North America Anti-Vimentin Antibody Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Anti-Vimentin Antibody Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Anti-Vimentin Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Anti-Vimentin Antibody Sales by Country (kg), 2021–2026
 Table 32. Europe Anti-Vimentin Antibody Sales by Country (kg), 2027–2032
 Table 33. Europe Anti-Vimentin Antibody Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Anti-Vimentin Antibody Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Anti-Vimentin Antibody Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Anti-Vimentin Antibody Sales by Region (kg), 2021–2026
 Table 37. Asia Pacific Anti-Vimentin Antibody Sales by Region (kg), 2027–2032
 Table 38. Asia Pacific Anti-Vimentin Antibody Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Anti-Vimentin Antibody Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Anti-Vimentin Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Anti-Vimentin Antibody Sales by Country (kg), 2021–2026
 Table 42. Latin America Anti-Vimentin Antibody Sales by Country (kg), 2027–2032
 Table 43. Latin America Anti-Vimentin Antibody Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Anti-Vimentin Antibody Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Anti-Vimentin Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Anti-Vimentin Antibody Sales by Country (kg), 2021–2026
 Table 47. Middle East and Africa Anti-Vimentin Antibody Sales by Country (kg), 2027–2032
 Table 48. Middle East and Africa Anti-Vimentin Antibody Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Anti-Vimentin Antibody Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Anti-Vimentin Antibody Sales (kg) by Type (2021–2026)
 Table 51. Global Anti-Vimentin Antibody Sales (kg) by Type (2027–2032)
 Table 52. Global Anti-Vimentin Antibody Sales Market Share by Type (2021–2026)
 Table 53. Global Anti-Vimentin Antibody Sales Market Share by Type (2027–2032)
 Table 54. Global Anti-Vimentin Antibody Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Anti-Vimentin Antibody Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Anti-Vimentin Antibody Revenue Market Share by Type (2021–2026)
 Table 57. Global Anti-Vimentin Antibody Revenue Market Share by Type (2027–2032)
 Table 58. Global Anti-Vimentin Antibody Price (US$/kg) by Type (2021–2026)
 Table 59. Global Anti-Vimentin Antibody Price (US$/kg) by Type (2027–2032)
 Table 60. Global Anti-Vimentin Antibody Sales (kg) by Application (2021–2026)
 Table 61. Global Anti-Vimentin Antibody Sales (kg) by Application (2027–2032)
 Table 62. Global Anti-Vimentin Antibody Sales Market Share by Application (2021–2026)
 Table 63. Global Anti-Vimentin Antibody Sales Market Share by Application (2027–2032)
 Table 64. Global Anti-Vimentin Antibody Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Anti-Vimentin Antibody Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Anti-Vimentin Antibody Revenue Market Share by Application (2021–2026)
 Table 67. Global Anti-Vimentin Antibody Revenue Market Share by Application (2027–2032)
 Table 68. Global Anti-Vimentin Antibody Price (US$/kg) by Application (2021–2026)
 Table 69. Global Anti-Vimentin Antibody Price (US$/kg) by Application (2027–2032)
 Table 70. Thermo Fisher Scientific Company Information
 Table 71. Thermo Fisher Scientific Description and Business Overview
 Table 72. Thermo Fisher Scientific Anti-Vimentin Antibody Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 73. Thermo Fisher Scientific Anti-Vimentin Antibody Product
 Table 74. Thermo Fisher Scientific Recent Developments/Updates
 Table 75. Nordic Company Information
 Table 76. Nordic Description and Business Overview
 Table 77. Nordic Anti-Vimentin Antibody Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 78. Nordic Anti-Vimentin Antibody Product
 Table 79. Nordic Recent Developments/Updates
 Table 80. Abcam Company Information
 Table 81. Abcam Description and Business Overview
 Table 82. Abcam Anti-Vimentin Antibody Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 83. Abcam Anti-Vimentin Antibody Product
 Table 84. Abcam Recent Developments/Updates
 Table 85. Genetex Company Information
 Table 86. Genetex Description and Business Overview
 Table 87. Genetex Anti-Vimentin Antibody Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 88. Genetex Anti-Vimentin Antibody Product
 Table 89. Genetex Recent Developments/Updates
 Table 90. PROGEN Company Information
 Table 91. PROGEN Description and Business Overview
 Table 92. PROGEN Anti-Vimentin Antibody Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 93. PROGEN Anti-Vimentin Antibody Product
 Table 94. PROGEN Recent Developments/Updates
 Table 95. Bio-Rad Company Information
 Table 96. Bio-Rad Description and Business Overview
 Table 97. Bio-Rad Anti-Vimentin Antibody Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 98. Bio-Rad Anti-Vimentin Antibody Product
 Table 99. Bio-Rad Recent Developments/Updates
 Table 100. Boster Bio Company Information
 Table 101. Boster Bio Description and Business Overview
 Table 102. Boster Bio Anti-Vimentin Antibody Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 103. Boster Bio Anti-Vimentin Antibody Product
 Table 104. Boster Bio Recent Developments/Updates
 Table 105. Sino Biological Company Information
 Table 106. Sino Biological Description and Business Overview
 Table 107. Sino Biological Anti-Vimentin Antibody Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 108. Sino Biological Anti-Vimentin Antibody Product
 Table 109. Sino Biological Recent Developments/Updates
 Table 110. Arigo Biolaboratories Company Information
 Table 111. Arigo Biolaboratories Description and Business Overview
 Table 112. Arigo Biolaboratories Anti-Vimentin Antibody Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 113. Arigo Biolaboratories Anti-Vimentin Antibody Product
 Table 114. Arigo Biolaboratories Recent Developments/Updates
 Table 115. Aves Labs Company Information
 Table 116. Aves Labs Description and Business Overview
 Table 117. Aves Labs Anti-Vimentin Antibody Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 118. Aves Labs Anti-Vimentin Antibody Product
 Table 119. Aves Labs Recent Developments/Updates
 Table 120. Raybiotech Company Information
 Table 121. Raybiotech Description and Business Overview
 Table 122. Raybiotech Anti-Vimentin Antibody Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 123. Raybiotech Anti-Vimentin Antibody Product
 Table 124. Raybiotech Recent Developments/Updates
 Table 125. Biolegend Company Information
 Table 126. Biolegend Description and Business Overview
 Table 127. Biolegend Anti-Vimentin Antibody Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 128. Biolegend Anti-Vimentin Antibody Product
 Table 129. Biolegend Recent Developments/Updates
 Table 130. Roche Diagnostics Company Information
 Table 131. Roche Diagnostics Description and Business Overview
 Table 132. Roche Diagnostics Anti-Vimentin Antibody Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 133. Roche Diagnostics Anti-Vimentin Antibody Product
 Table 134. Roche Diagnostics Recent Developments/Updates
 Table 135. Rockland Immunochemicals Company Information
 Table 136. Rockland Immunochemicals Description and Business Overview
 Table 137. Rockland Immunochemicals Anti-Vimentin Antibody Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 138. Rockland Immunochemicals Anti-Vimentin Antibody Product
 Table 139. Rockland Immunochemicals Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Anti-Vimentin Antibody Distributors List
 Table 143. Anti-Vimentin Antibody Customers List
 Table 144. Anti-Vimentin Antibody Market Trends
 Table 145. Anti-Vimentin Antibody Market Drivers
 Table 146. Anti-Vimentin Antibody Market Challenges
 Table 147. Anti-Vimentin Antibody Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Anti-Vimentin Antibody
 Figure 2. Global Anti-Vimentin Antibody Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Anti-Vimentin Antibody Market Share by Type: 2025 & 2032
 Figure 4. Monoclonal Anti-Vimentin Antibody Product Picture
 Figure 5. Polyclonal Anti-Vimentin Antibody Product Picture
 Figure 6. Global Anti-Vimentin Antibody Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Anti-Vimentin Antibody Market Share by Application: 2025 & 2032
 Figure 8. Immunocytochemistry
 Figure 9. Flow Cytometry
 Figure 10. Immunochemistry
 Figure 11. Western Blot
 Figure 12. Others
 Figure 13. Global Anti-Vimentin Antibody Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global Anti-Vimentin Antibody Market Size (US$ Million), 2021–2032
 Figure 15. Global Anti-Vimentin Antibody Sales (kg), 2021–2032
 Figure 16. Global Anti-Vimentin Antibody Average Price (US$/kg), 2021–2032
 Figure 17. Anti-Vimentin Antibody Report Years Considered
 Figure 18. Anti-Vimentin Antibody Sales Share by Manufacturers in 2025
 Figure 19. Global Anti-Vimentin Antibody Revenue Share by Manufacturers in 2025
 Figure 20. Top 5 and Top 10 Global Anti-Vimentin Antibody Players: Market Share by Revenue in Anti-Vimentin Antibody in 2025
 Figure 21. Anti-Vimentin Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 22. Global Anti-Vimentin Antibody Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 23. North America Anti-Vimentin Antibody Sales Market Share by Country (2021–2032)
 Figure 24. North America Anti-Vimentin Antibody Revenue Market Share by Country (2021–2032)
 Figure 25. United States Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Canada Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. Europe Anti-Vimentin Antibody Sales Market Share by Country (2021–2032)
 Figure 28. Europe Anti-Vimentin Antibody Revenue Market Share by Country (2021–2032)
 Figure 29. Germany Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. France Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. U.K. Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Italy Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Russia Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Asia Pacific Anti-Vimentin Antibody Sales Market Share by Region (2021–2032)
 Figure 35. Asia Pacific Anti-Vimentin Antibody Revenue Market Share by Region (2021–2032)
 Figure 36. China Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Japan Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. South Korea Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. India Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Australia Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. China Taiwan Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Southeast Asia Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Latin America Anti-Vimentin Antibody Sales Market Share by Country (2021–2032)
 Figure 44. Latin America Anti-Vimentin Antibody Revenue Market Share by Country (2021–2032)
 Figure 45. Mexico Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Brazil Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Argentina Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Colombia Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Middle East and Africa Anti-Vimentin Antibody Sales Market Share by Country (2021–2032)
 Figure 50. Middle East and Africa Anti-Vimentin Antibody Revenue Market Share by Country (2021–2032)
 Figure 51. Turkey Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Saudi Arabia Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. UAE Anti-Vimentin Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Global Sales Market Share of Anti-Vimentin Antibody by Type (2021–2032)
 Figure 55. Global Revenue Market Share of Anti-Vimentin Antibody by Type (2021–2032)
 Figure 56. Global Anti-Vimentin Antibody Price (US$/kg) by Type (2021–2032)
 Figure 57. Global Sales Market Share of Anti-Vimentin Antibody by Application (2021–2032)
 Figure 58. Global Revenue Market Share of Anti-Vimentin Antibody by Application (2021–2032)
 Figure 59. Global Anti-Vimentin Antibody Price (US$/kg) by Application (2021–2032)
 Figure 60. Anti-Vimentin Antibody Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String